Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 7 de dic. de 2012 · The AES addresses characteristics of goal directed behavior that reflects apathy including behavioral, cognitive, and emotional indicators.

  2. Hace 5 días · The Apathy Evaluation Scale (AES) was developed by Marin (1991) as a method for measuring apathy resulting from brain-related pathology. He defined apathy as “lack of motivation not attributable to diminished level of consciousness, cognitive impairment, or emotional distress.” (Marin, 1991).

  3. 12 de sept. de 2021 · The Apathy Evaluation Scale (AES-C) is a 4-point Likert scale consisting of 18 items. It requires 10–20 min to administer depending on the subject’s abilities and the version used. In the Clinician Version, a categorisation of items is indicated in the right column: B = behavioural item; C = cognitive item; E = emotional item.

  4. 12 de sept. de 2021 · The Apathy Evaluation Scale (AES-C) is a 4-point Likert scale consisting of 18 items. It requires 10–20 min to administer depending on the subject’s abilities and the version used. In the Clinician Version, a categorisation of items is indicated in the right column: B = behavioural item; C = cognitive item; E = emotional item.

  5. The 18-item Apathy Evaluation Scale (AES; Marin, Biedrzycki, & Firinciogullari, 1991) was developed to assess apathy in adult patients with clinical disorders. There are three versions of this measure: clinician (AES-C), informant (AES-I), and self-rated (AES-S) versions-- each with the same (core) item types covering cognitive, behavioral, and ...

  6. It has three versions: self-rated (AES-S), clinician-rated (AES-C), and informant-rated (AES-I). Using factor analysis, Marin and colleagues identified three factors for the scale, including general apathy, disinterest or amotivation, and lack of concern.

  7. The Apathy Evaluation Scale was developed by Robert S. Marin, M.D. Development and validation studies are described in Marin et al., 1991 [see References]. Supplementary administration guidelines are available from the author. *Reprinted from Seminars in Clinical Neuropsychiatry, Vol 1(4), Marin RS, Apathy: